ATE363913T1 - Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis - Google Patents
Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsisInfo
- Publication number
- ATE363913T1 ATE363913T1 AT99909244T AT99909244T ATE363913T1 AT E363913 T1 ATE363913 T1 AT E363913T1 AT 99909244 T AT99909244 T AT 99909244T AT 99909244 T AT99909244 T AT 99909244T AT E363913 T1 ATE363913 T1 AT E363913T1
- Authority
- AT
- Austria
- Prior art keywords
- tcf
- sepsis
- preventives
- treat
- remedies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Water Treatment By Sorption (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10070914A JPH11269091A (ja) | 1998-03-19 | 1998-03-19 | 敗血症予防及び／又は治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE363913T1 true ATE363913T1 (de) | 2007-06-15 |
Family
ID=13445266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99909244T ATE363913T1 (de) | 1998-03-19 | 1999-03-19 | Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060251615A1 (de) |
| EP (1) | EP0982037B1 (de) |
| JP (1) | JPH11269091A (de) |
| KR (1) | KR100572044B1 (de) |
| AT (1) | ATE363913T1 (de) |
| AU (1) | AU753198B2 (de) |
| CA (1) | CA2288881A1 (de) |
| DE (1) | DE69936248T2 (de) |
| DK (1) | DK0982037T3 (de) |
| ES (1) | ES2288014T3 (de) |
| TW (1) | TW518229B (de) |
| WO (1) | WO1999047155A1 (de) |
| ZA (1) | ZA997352B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び／又は治療剤 |
| ATE344050T1 (de) | 1997-03-14 | 2006-11-15 | Daiichi Seiyaku Co | Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
| KR100260964B1 (ko) * | 1992-07-16 | 2000-07-01 | 쇼노 카츄야 | Tcf-ii를 유효성분으로 하는 혈액응고 정상화제 |
| CA2100720C (en) * | 1992-07-16 | 2003-03-11 | Hiroaki Masunaga | Medicinal composition comprising tcf-ii |
-
1998
- 1998-03-19 JP JP10070914A patent/JPH11269091A/ja active Pending
-
1999
- 1999-03-19 AU AU28536/99A patent/AU753198B2/en not_active Ceased
- 1999-03-19 EP EP99909244A patent/EP0982037B1/de not_active Expired - Lifetime
- 1999-03-19 CA CA002288881A patent/CA2288881A1/en not_active Abandoned
- 1999-03-19 KR KR1019997010648A patent/KR100572044B1/ko not_active IP Right Cessation
- 1999-03-19 DK DK99909244T patent/DK0982037T3/da active
- 1999-03-19 ES ES99909244T patent/ES2288014T3/es not_active Expired - Lifetime
- 1999-03-19 TW TW088104280A patent/TW518229B/zh not_active IP Right Cessation
- 1999-03-19 WO PCT/JP1999/001373 patent/WO1999047155A1/ja active IP Right Grant
- 1999-03-19 DE DE69936248T patent/DE69936248T2/de not_active Expired - Fee Related
- 1999-03-19 AT AT99909244T patent/ATE363913T1/de not_active IP Right Cessation
- 1999-11-26 ZA ZA9907352A patent/ZA997352B/xx unknown
-
2005
- 2005-07-21 US US11/186,638 patent/US20060251615A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0982037B1 (de) | 2007-06-06 |
| US20060251615A1 (en) | 2006-11-09 |
| DE69936248D1 (de) | 2007-07-19 |
| DK0982037T3 (da) | 2007-10-08 |
| ES2288014T3 (es) | 2007-12-16 |
| CA2288881A1 (en) | 1999-09-23 |
| WO1999047155A1 (fr) | 1999-09-23 |
| KR20010012687A (ko) | 2001-02-26 |
| EP0982037A4 (de) | 2004-10-13 |
| AU2853699A (en) | 1999-10-11 |
| ZA997352B (en) | 2000-05-29 |
| KR100572044B1 (ko) | 2006-04-17 |
| TW518229B (en) | 2003-01-21 |
| EP0982037A1 (de) | 2000-03-01 |
| AU753198B2 (en) | 2002-10-10 |
| DE69936248T2 (de) | 2008-01-31 |
| JPH11269091A (ja) | 1999-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004911D0 (no) | Antitumormiddel | |
| YU21401A (sh) | Tetrahidropiridoetri | |
| EA200600618A1 (ru) | Применение эффекторов глутаминил- и глутаматциклаз | |
| DE59903921D1 (de) | Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen | |
| AP2000001942A0 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections. | |
| TR200100874T2 (tr) | Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi | |
| TR200200883T2 (tr) | 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları | |
| DE69927688D1 (de) | Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs | |
| FR2751879B1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
| DE69823493D1 (de) | Tetrahydropyridoverbindungen | |
| ATE222119T1 (de) | Verwendung von erythropoietin zur behandlung von multiple myelom | |
| WO2003017939A3 (en) | Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment | |
| TR199801732T2 (xx) | Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri. | |
| PT1140113E (pt) | Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos | |
| ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
| ATE363913T1 (de) | Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis | |
| DE60035133D1 (de) | Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten | |
| DE3784768D1 (de) | Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen. | |
| AU4302996A (en) | Uracil derivatives | |
| JPS5217946A (en) | Underlay for shoes sterilized by copper | |
| DE60119130D1 (de) | Behandlung von tumoren mit azetylenen disubstituiert mit einer heteroaromatischen gruppe und mit einer substituierten thiochromanyl gruppe in kombination mit anderen antitumormitteln | |
| ATE86863T1 (de) | Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen. | |
| HK1045253A1 (en) | Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis | |
| ATE95062T1 (de) | Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens. | |
| BG105763A (en) | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 0982037 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |